Impact of Failed Thrombolysis: Clinical Outcomes in a PCI-Capable Setting
DOI:
https://doi.org/10.52206/jsmc.2025.15.3.1128Abstract
Background: Streptokinase remains the primary mode of reperfusion therapy in many centers, including some with percutaneous coronary intervention (PCI) capabilities. According to the pharmacoinvasive strategy, all ST-elevation myocardial infarction (STEMI) patients who receive thrombolysis should undergo routine angiography, while those with failed thrombolysis must undergo urgent rescue PCI. However, the rate of complications following unsuccessful thrombolysis and the frequency of rescue PCI are not well studied in our setting.
Objective: To determine the frequency of rescue PCI and compare the rates of in-hospital complications between successfully and unsuccessfully thrombolysed STEMI patients.
Methodology: Patients receiving intravenous streptokinase for their first STEMI were enrolled 90 minutes post-infusion. Patients with cardiogenic shock, third-degree heart block, acute left ventricular failure, or left bundle branch block before thrombolysis, and those with contraindications to thrombolysis or who declined participation, were excluded. Patients were followed until discharge to assess the incidence of cardiogenic shock, left ventricular failure, left ventricular dysfunction, acute kidney injury, and in-hospital death. Outcomes were compared between patients with successful versus unsuccessful thrombolysis. The frequency of rescue PCI was also recorded.
Results: A total of 391 patients were included, with males comprising 75% of the sample. The most prevalent comorbidities were diabetes (54%) and hypertension (32%). Anterior and inferior wall STEMI each accounted for 36% of cases. Thrombolysis was successful in 73% and unsuccessful in 27% of patients. Mortality was 7.3% in successfully thrombolysed patients and 14% in the unsuccessful group. All pre-specified complications were significantly more common in the failed thrombolysis group. Only 19% of patients underwent rescue PCI.
Conclusion: Streptokinase-based thrombolysis results in suboptimal reperfusion in a significant proportion of STEMI patients. Furthermore, the rate of rescue PCI among these high-risk individuals remains low. There is a critical need to enhance reperfusion strategies in PCI-capable settings.
Keywords: Rescue PCI, Streptokinase, ST-segment elevation myocardial infarction, Unsuccessful thrombolysis.
References
Robert AB, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. ESC Scientific Document Group, 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology. European Heart Journal. 2023;44(38):3720-826. https://doi.org/10.1093/eurheartj/ehad191
Mughal LH, Sastry S. Advances in the treatment of ST Elevation Myocardial Infarction in the UK. JRSM Cardiovascular Disease. 2022;(11). https://doi.org/10.1177/20480040221075519
William J. French, Mic Gunderson, Travis D, Bieniarz M, Zegre J Hemsey. Emergency Interhospital Transfer of Patients With ST Segment–Elevation Myocardial Infarction: Call 911—The American Heart Association Mission: Lifeline Program. JAHA. 2022;11(22). https://doi.org/10.1161/JAHA.122.026700
Sawar S, Khan B, Khan AT, Noor N, Rahman F, Rehman N. Complications of streptokinase in patients with acute ST segment elevation myocardial infarction: No reason to withhold this effective therapy. J Postgrad Med Inst. 2019;33(4):293-8. https://jpmi.org.pk/index.php/jpmi/article/view/2494
Steg G, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, et al. For the PERM Study Group. Efficacy of Streptokinase, but not Tissue-Type Plasminogen Activator, in Achieving 90-minute patency after thrombolysis for acute Myocardial Infarction decreases with time to treatment. JACC. 1998; 31(4):776-9. https://doi.org/10.1016/S0735-1097(98)00018-7
Zeb S, Hafizullah M, Jan H, Adil M, Zeb R. ST elevation myocardial infarction: An experience at Lady Read ing Hospital Peshawar, Pakistan. Khyber Med Univ J. 2017; 9(2): 60-2. https://www.kmuj.kmu.edu.pk/article/view/15541
Ahmad F, Ullah I, Farhad A, Ahmad W, Qfridi A khan, Rauf MA. Thrombolytic Therapy success rate and time to thrombolysis in patients with ST-Elevation Myocardial Infarction. Khyber Journal of Medical Sciences. 2024;17(2):88-93. https://doi.org/10.70520/kjms.v17i2.524
Saleem S, Khan A, Shafiq I. Post thrombolytic resolution of ST elevation in STEMI patients. Pak J Med Sci. 2016;32(1):201-5. https://doi.org/10.12669/pjms.321.8974
Imad M, Khalil AA, Waqar H, Babar FU, Shah SA, Ullah SA, et al. Factors Influencing Post-Thrombolytic ST-Segment Resolution in STEMI Patients: A Cross-Sectional Study from a Tertiary Care Hospital. Pak Heart J. 2025;58(01). https://doi.org/10.47144/phj.v58i1.2805
Babar MZ, Majid A, Iqbal J. Acute myocardial infarction; effects of thrombolysis on TIMI flow rate in infarct related artery (IRA) in patients of ST elevated acute myocardial infarction. Professional Med J. 2016;23(11):1412-1416. https://doi.org/10.17957/TPMJ/16.3557
Jibran MS, Khan SB, Habib SA, Zahid Z, Gul AM. Minutes are muscle and delay is death. J Postgrad Med Inst. 2020;34(1): 5-10.
Shaikh MK, Ali Shah SZ, Kumar C, Lohano M, Talpur AS, Zahoor A, et al. Accuracy of Resolution of ST-Segment Elevation in Electrocardiogram to Determine the Patency of Infarct-Related Artery. Cureus. 2021 Apr 13;13(4):e14448. https://doi.org/10.7759/cureus.14448
Elias B. Hanna. Practical Cardiovascular Medicine. 2nd Edition. Chapter 2. ST-Segment Elevation Myocardial Infarction: pages 38-73. ISBN:9781119832737. 2022 John Wiley & Sons Ltd.101002/978119832737. https://doi.org/10.1002/9781119832737.ch2
Ahmed A, Ali R, Farid G, Saqib A, Ali M, Muneeb M, et al. Mortality Outcomes and Predictors of Failed Thrombolysis following STEMI Thrombolysis in a Non-PCI Capable Tertiary Hospital. Pakistan Journal of Medical & Health Sciences. 2025;19(3):20–24. https://doi.org/10.53350/pjmhs02025193.5
Banning AS, Sabaté M, Orban M, Gracey J, López-Sobrino T, Massberg S, et al. Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial. EuroIntervention. 2023 Aug 21;19(6):482-492.10.4244/EIJ-D-23-00204. https://doi.org/10.4244/EIJ-D-23-00204
American Diabetes Association; Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 1 January 2021; 44 (Supplement_1): S15–S33. https://doi.org/10.2337/dc21-S002
Koh HP, Md Redzuan A, MohdSaffian S, Hassan H, R Nagarajah J, Ross NT. Mortality outcomes and predictors of failed thrombolysis following STEMI thrombolysis in a non-PCI capable tertiary hospital: a 5-year analysis. Intern Emerg Med. 2023;18(4):1169-1180. https://doi.org/10.1007/s11739-023-03202-1
Singh PK, Jha AK, Jha UC. Observational Study on Failure of Thrombolysis with Streptokinase in Acute Myocardial Infarction Using ECG Criteria. International Journal of Pharmaceutical and Clinical Research. 2024; 16(6); 1050-1053. e-ISSN: 0975-1556.2820-2643.
Wu C, Li L, Wang S. Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry. BMC Cardiovasc Disord. 2023.(23) 103. https://doi.org/10.1186/s12872-023-03105-1
Mauri F, Maggioni AP, Franzosi MG, de Vita C, Santoro E, Santoro L, et al. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopra vvivenzanell' Infarto Miocardico (GISSI-2)-Derived Analysis. J Am Coll Cardiol. 1994 Sep;24(3):600-7. 10.1016/0735-1097(94)90003-5. Erratum in: J Am Coll Cardiol. 1995 Mar 1;25(3):805. https://doi.org/10.1016/0735-1097(94)90003-5
Ross AM, Lundergan CF, Rohrbeck SC. For the GUSTO-1 Angiographic investigators. Rescue angioplasty after failed thrombolysis technical and clinical outcomes in a large thrombolysis trial. J Am Coll Cardiol. 1998;31:1511-7. https://doi.org/10.1136/heart.85.1.104
Gershlick AH, Lloyd AS, Hughes S, Abrams KR, Suzanne E, Stevens, et al. For the REACT Trial investigators. Rescue Angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005; 353:2758-68. https://doi.org/10.1056/NEJMoa050849
Azzahhafi J, Sangen VD, Yin CP, Henriques JPS, Kikkert WJ, Berg T. FORCE-ACS, The risk-treatment paradox in acute coronary syndrome patients: insights from the FORCE-ACS registry, European Heart Journal. 2021;42(1); https://doi.org/10.1093/eurheartj/ehab724.1406.33
McAlister. The End of the Risk–Treatment Paradox?: A Rising Tide Lifts All Boats. JACC. 2011;58(17)1766-7. https://doi.org/10.1016/j.jacc.2011.07.028
Pereiraa H, Caléb R, Pereirac E, Mellod S, Vitorinob S, Sousae PD, et al. On behalf of the centers participating in the ‘‘Stent for Life’’ Initiative Portugal. Portuguese Journal of Cardiology. 2021;40:81-90. https://doi.org/10.1016/j.repc.2020.05.018
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
